<--- Back to Details
First PageDocument Content
Hormonal contraception / Fertility / Gynaecology / Pregnancy / Obstetrics / Ulipristal acetate / Emergency contraception / Mifepristone / Selective progesterone receptor modulator / Endocrine system / Medicine / Human reproduction
Date: 2012-07-19 11:46:49
Hormonal contraception
Fertility
Gynaecology
Pregnancy
Obstetrics
Ulipristal acetate
Emergency contraception
Mifepristone
Selective progesterone receptor modulator
Endocrine system
Medicine
Human reproduction

MYTH AND FACT: THE TRUTH ABOUT ELLA

Add to Reading List

Source URL: downloads.frc.org

Download Document from Source Website

File Size: 170,20 KB

Share Document on Facebook

Similar Documents

Articles  Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis Anna F Glasier, Sharon T Cameron, Paul M Fine, Susan J S Logan, William Casale, Jennife

Articles Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis Anna F Glasier, Sharon T Cameron, Paul M Fine, Susan J S Logan, William Casale, Jennife

DocID: 1gsp4 - View Document

About HRA Pharma HRA Pharma is a leading pharmaceutical company with a unique leadership position within niche areas of women’s health and endocrinology. The company is committed to understanding evolving health needs,

About HRA Pharma HRA Pharma is a leading pharmaceutical company with a unique leadership position within niche areas of women’s health and endocrinology. The company is committed to understanding evolving health needs,

DocID: 1ahKh - View Document

Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medicines Consortium. The detailed advice for each medicine that

Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medicines Consortium. The detailed advice for each medicine that

DocID: 176U9 - View Document

23 April 2015 EMA/CHMPCommittee for Medicinal Products for Human Use (CHMP) Summary of opinion 1 (post authorisation)

23 April 2015 EMA/CHMPCommittee for Medicinal Products for Human Use (CHMP) Summary of opinion 1 (post authorisation)

DocID: 16soR - View Document

Emerging Female,  Male, and Post-coital methods.xls

Emerging Female, Male, and Post-coital methods.xls

DocID: 14ij8 - View Document